Tongda Electric(603390)2025-04-29 03:10Dividend Distribution - The company plans to distribute a cash dividend of 0.40 CNY per 10 shares, totaling approximately 14,066,879.36 CNY for the 2024 fiscal year, which represents 96.13% of the net profit attributable to shareholders[4]. - The total cash dividends distributed for the 2024 fiscal year, including the mid-year distribution, will amount to 24,617,488.88 CNY[4]. - The company has completed the mid-year cash dividend distribution of 10,550,609.52 CNY, which was approved at the 2023 annual shareholders' meeting[4]. Financial Performance - The company reported a revenue of 1.2 billion CNY for the fiscal year 2024, representing a 15% increase compared to the previous year[16]. - The company's operating revenue for 2024 reached ¥665,675,804.64, representing a year-on-year increase of 16.62% compared to ¥570,796,613.42 in 2023[26]. - The net profit attributable to shareholders for 2024 was ¥25,607,959.94, up 10.52% from ¥23,171,294.18 in 2023[26]. - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 50.70% to ¥16,303,656.95 from ¥10,818,438.05 in 2023[26]. - The basic earnings per share for 2024 remained at ¥0.07, unchanged from 2023, while diluted earnings per share also stayed at ¥0.07[27]. Risk Management - The company has disclosed potential risk factors in its operations, which investors should be aware of[8]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[7]. - There are no violations of decision-making procedures regarding external guarantees[8]. Audit and Compliance - The company has received a standard unqualified audit report from Tianjian Accounting Firm[3]. - The board of directors and senior management have confirmed the accuracy and completeness of the annual report[3]. - The company has established internal control measures for subsidiaries to ensure compliance and promote healthy development[182]. Research and Development - The board has approved a budget of 200 million CNY for R&D initiatives in the upcoming fiscal year[16]. - R&D investment amounted to 58.29 million yuan, with 34 new projects initiated and 36 projects completed during the reporting period[39]. - The company maintains a strong focus on R&D, with a team of 194 researchers, including 14 senior engineers, to drive innovation and product development[75]. Market Expansion and Strategy - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by 2025[16]. - The company is implementing a new ERP system to streamline operations and improve data analytics capabilities[16]. - The company is actively developing new products in mobile healthcare, including various mobile medical vehicles and services[54]. Customer and Sales Insights - User data indicates a growth in active users by 25%, reaching 500,000 users by the end of 2024[16]. - The company’s top five customers accounted for 50.33% of total sales, indicating a moderate reliance on a few key clients[91]. - The company’s main business experiences seasonal fluctuations, with the first half being a sales off-season and the second half, particularly Q4, being a peak season[130]. Environmental and Social Responsibility - The company invested 32.36 million yuan in environmental protection during the reporting period[187]. - The company reduced carbon emissions by 740.56 tons through various measures, including the implementation of a photovoltaic power generation project[192]. - The company made a total donation of 10.24 million yuan for public welfare projects[193]. Governance and Management - The company held a total of 9 board meetings during the year, with 6 conducted via communication and 3 combining on-site and communication methods[157]. - The total remuneration for all listed directors and supervisors amounted to 8,442,300 RMB, with a slight decrease of 523,800 shares in total holdings[140]. - The company appointed new independent directors, including Guo Xiangdong, Lü Weirong, and Yan Yajun, following the expiration of the previous independent directors' terms[147].